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Abstract
Background: Previous surveys on the relationship between physicians and pharmaceutical representatives (PRs) have been
of limited quality. The purpose of our survey of practicing physicians in Japan was to assess the extent of their involvement
in pharmaceutical promotional activities, physician characteristics that predict such involvement, attitudes toward
relationships with PRs, correlations between the extent of involvement and attitudes, and differences in the extent of
involvement according to self-reported prescribing behaviors.
Methods and Findings: From January to March 2008, we conducted a national survey of 2621 practicing physicians in seven
specialties: internal medicine, general surgery, orthopedic surgery, pediatrics, obstetrics-gynecology, psychiatry, and
ophthalmology. The response rate was 54%. Most physicians met with PRs (98%), received drug samples (85%) and
stationery (96%), and participated in industry-sponsored continuing medical education (CME) events at the workplace (80%)
and outside the workplace (93%). Half accepted meals outside the workplace (49%) and financial subsidies to attend CME
events (49%). Rules at the workplace banning both meetings with PRs and gifts predicted less involvement of physicians in
promotional activities. Physicians valued information from PRs. They believed that they were unlikely to be influenced by
promotional activities, but that their colleagues were more susceptible to such influence than themselves. They were
divided about the appropriateness of low-value gifts. The extent of physician involvement in promotional activities was
positively correlated with the attitudes that PRs are a valuable source of information and that gifts are appropriate. The
extent of such involvement was higher among physicians who prefer to ask PRs for information when a new medication
becomes available, physicians who are not satisfied with patient encounters ending only with advice, and physicians who
prefer to prescribe brand-name medications.
Conclusions: Involvement in pharmaceutical promotional activities is widespread among practicing physicians in Japan. The
extent of such involvement varies according to certain physician characteristics. As a group, they are at risk for influence by
promotional activities.
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Introduction
In the past few decades, the relationship between physicians and
the pharmaceutical industry has been one of the most controver-
sial issues in medicine. Pharmaceutical representatives (PRs) have
direct contact with physicians and play a key role in the
promotional activities of the pharmaceutical industry. Previous
surveys have examined conflicts of interest in physicians’
relationships with PRs. These studies found that many physicians
met PRs frequently [1–11] and were involved in a variety of
promotional activities [3,5,6,9,11–16]. Physicians variably rated
the informational value of PRs in medical education [1–3,5–8,
10,12,15–18]. Their beliefs about the influence of interactions
with PRs on prescribing behaviors were mixed [1,3,5–8,10,13,
14,16,18,19]. They believed that their colleagues were more likely
to be influenced than themselves [13,14,16,19]. Physicians tended
to believe that it was appropriate to receive inexpensive gifts
[2,6,8,14,16,18,19]. Physicians who met with PRs frequently were
more likely to prescribe medications that are not clinically
indicated [20], and to rely less on information from published
research findings when a new medication becomes available [20].
However, the quality of these surveys was limited because of their
small sample sizes [1–10,12–19], the use of accessible and
convenience samples such as residents and faculty members in
academic medical centers [1–3,5,7,9,14–16,18], and the lack of
comprehensive exploration of the relationships among physician
characteristics, involvement in promotional activities, attitudes,
and prescribing behaviors [11,20].
We conducted a national survey of practicing physicians in
Japan. The purpose of the survey was to answer five questions
regarding physician involvement in promotional activities, by
which we mean meeting with PRs, receiving gifts, and participat-
ing in promotional events. First, what is the extent of physician
involvement in promotional activities? Second, what physician
PLoS ONE | www.plosone.org 1 August 2010 | Volume 5 | Issue 8 | e12193characteristics predict such involvement? Third, what attitudes do
physicians have toward relationships with PRs? Fourth, are there
correlations between the extent of the involvement and their
attitudes? Finally, are there differences in the extent of the
involvement according to self-reported prescribing behaviors?
Methods
Survey Design
The study was a cross-sectional survey that used a 26-item, 4-
page, anonymous, self-administered questionnaire. The question-
naire was developed based on literature review [1,5,11,14,20] and
discussions between two authors (SS, KM). The questionnaire
sought characteristics of the respondents, frequency of involve-
ment in pharmaceutical promotional activities, attitudes toward
relationships with PRs, and self-reported prescribing behaviors
(File S1). The questionnaire was not pretested for its validity and
reliability before being administered in the study. The ethics
committee at Kawasaki Saiwai Hospital approved the survey
protocol.
Characteristics of the respondents. In addition to sex,
years in practice, specialty and practice setting, we asked how
much opportunity respondents had had to learn physician-
industry relationships and critical appraisal skills on a five-point
scale (none, little, a little, some, substantial) and whether their
workplaces had rules banning meetings with PRs, gifts, or both
(File S1).
Involvement in promotional activities. Respondents were
asked to report the frequency of meetings with PRs and receiving
or participating in various types of gifts or promotional events on a
five-point scale: never=0, less than once a month=1, two to three
times a month=2.5, once a week=4, two to three times a
week=10, nearly every day=20 (File S1). Responses to these
questions were summed to create a ‘‘Promotional Activity Index
Score’’ (range 0–140). The score expressed the frequency of
meeting with PRs and receiving gifts or participating in the
promotional events listed in our survey in a typical four-week
period.
Attitudes toward relationships with PRs. We asked
respondents to report their degree of agreement with a series of
eight statements about relationships with PRs on a five-point scale:
agree, somewhat agree, neutral, somewhat disagree, and disagree
(File S1). Principal component factor analysis for these eight
statements extracted three factors (File S2). They consisted of three
items (statement 3a, 3b, 3c) for which agreement suggests that
respondents believe that PRs are a valuable source of information
(‘Informational Value Scale’), three items (statement 3d, 3e, 3f) for
which disagreement suggests that they are immune from influence
by interactions with PRs (‘Immunity Scale’), and two items
(statement 3g, 3h) for which agreement suggests that they believe
receiving gifts is appropriate (‘Appropriateness Scale’). The points
for each of these three scales were converted to a summary score
ranging from 0 to 1.0 (File S3). A score of 0 was assigned to
physician perception of PRs as having minimal informational value,
themselves as minimally immune to promotion, and gifts as totally
inappropriate.Ascoreof1.0wasassigned tophysicianperceptionof
PRs as having maximal informational value, themselves as
maximally immune to promotion, and gifts as totally appropriate.
Prescribing behaviors. Respondents were asked about four
questions relating to their prescribing behaviors (File S1).
Survey Sample
The target population was practicing physicians both in office
and hospital settings in Japan. According to a national survey of
physicians’ demographic characteristics [21], the total number of
physicians in Japan in 2004 was 270,371, of which 92,985
physicians worked in office settings and 163,683 physicians worked
in hospital settings. We were unable to sample randomly because
there is no complete up-to-date registry of all physicians in Japan.
We used internet search engines to identify our survey partici-
pants. In order to ensure representativeness of our sample, we pre-
specified inclusion criteria based on a national survey of physicians
as follows [21]: We included internists, general surgeons,
orthopedic surgeons, pediatricians, obstetrician-gynecologists,
psychiatrists, and ophthalmologists because these were the seven
most numerous specialties in Japan. Equal numbers of office-based
and hospital-based physicians were included because the national
survey showed the ratio of the number of office-based and
hospital-based practicing physicians was approximately one to one
[21]. We included 4 office-based and 4 hospital-based physicians
practicing in each of 7 specialties for all 47 Japanese prefectures.
We excluded those who worked in academic medical centers, were
retired or on leave, or were in administrative positions in hospitals.
Survey Administration
The surveys were administered from January to March 2008.
To build participant expectations, a pre-notification postcard was
sent to all participants. Five days after sending the pre-notification
postcard, we sent every participant a cover letter, a questionnaire,
a self-addressed postcard with an individual participant’s name, a
stamped reply envelope, and a 500 yen (approximately US$5)
prepaid gift card for use at bookstores as an incentive. The cover
letter explained the purpose of the study, the voluntary nature of
participation, and the confidentiality of responses. We asked
participants to return the completed questionnaire separately from
the self-addressed postcard. The postcard allowed us to track non-
respondents while maintaining the anonymity of respondents.
Non-respondents received up to two reminders along with copies
of the original questionnaire at two-week intervals. We made clear
to participants that the study was sponsored by the Ministry of
Education, Culture, Sports, Science and Technology (MEXT) in
order to assure them of its credibility.
A questionnaire was considered to be evaluable when it was
returned by the pre-specified deadline (March 17, 2008) and had
complete information for 80% or more of all 26 items. Multiple
responses to a question for which a single response was appropriate
were considered to be no answer and not evaluable. In order to
ensure completeness and accuracy of data entry, two of the authors
(SS, KM) independently entered the data into Microsoft Excel.
Then two datasets were compared by the same two authors
independently. Errors in data entry were corrected. Disagreements
were resolved through discussion.
Statistical Analysis
Multivariate logistic regression models were used to assess
associations between physician characteristics and involvement in
promotional activities. We performed pairwise comparisons of
each specialty with every other specialty. Bonferroni corrections
were used to adjust for multiple comparisons (a total of 29). A p
value of less than 0.0017 (0.05 divided by 29) was considered to
indicate statistically significant differences between specialties.
Wilcoxon’s signed rank test was used to compare perceptions
about informational value of PRs for new vs. well-established
medications and perceptions about a participant’s own immunity
vs. others’ immunity to influence. Pearson product-moment
correlations were used to characterize relationships between
Promotional Activity Index Score and each of three attitudinal
scores. T-tests were used to compare Promotional Activity Index
Physicians and Pharma Industry
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prescribing behaviors. For multivariate logistic regression analyses,
odds ratios with 95% confidence intervals were calculated. For all
of the statistical analyses except for the analysis of multiple
comparisons between specialties, p values of less than 0.05 were
considered to be statistically significant. All p values were 2-tailed.
SPSS, version 16.0 was used for all statistical analyses.
Results
Study Population
We identified a total of 2632 physicians via an internet search
based on our pre-specified inclusion and exclusion criteria, and we
sent the survey questionnaire to all of them. Of the 2632
physicians, 11 were ineligible to participate in the survey because
they were not providing patient care, out of the country, or
practicing in a specialty not included in the survey. We were
unable to contact 34 physicians, and 22 declined to answer.
Thirty-one answer sheets were incomplete. Of the 2621 judged to
be either eligible or of unknown eligibility, 1411 physicians
completed the survey, for a response rate of 54%. We referred to
the standard definitions of the American Association for Public
Opinion Research to calculate the response rate [22].
The characteristics of the respondents are shown in Table 1.
The proportions of women to men and of office-based to hospital-
based physicians among our respondents were slightly different
from the national proportions in 2004 (23% vs. 17% women and
58% vs. 45% office-based physicians, respectively) [21]. The
distribution of years in practice approximated the national
distribution, and the distribution among specialties was not skewed
toward one particular group. Twenty-six percent of respondents
reported having had opportunities to learn physician-industry
relationships and 47% reported having learned critical appraisal
skills. Seventy-six percent reported that their workplaces did not
Table 1. Characteristics of 1411 survey respondents.
Characteristic Respondents
No./Total No. Percentage*
Sex
Male 1084/1410 77
Female 326/1410 23
No. of years in practice
10 yr. or less 339/1410 24
11–20 yr. 488/1410 35
21–30 yr. 428/1410 30
31 yr. or more 155/1410 11
Specialty
Internal Medicine 214/1409 15
General surgery 181/1409 13
Orthopedic surgery 177/1409 13
Pediatrics 221/1409 16
Obstetrics/gynecology 210/1409 15
Psychiatry 197/1409 14
Ophthalmology 209/1409 15
Practice setting
Office 822/1410 58
Hospital 588/1410 42
Having had opportunities to learn physician-industry relationships**
Yes 370/1406 26
No 1036/1406 74
Having had opportunities to learn critical appraisal skills**
Yes 666/1406 47
No 740/1406 53
Rules banning meetings with PRs and/or gifts at the workplace
Yes Rules banning both meetings with PRs and gifts 63/1391 5
Rules banning meetings with PRs, not gifts 54/1391 4
Rules banning gifts, not meetings with PRs 217/1391 16
No 1057/1391 76
Abbreviation: PR, pharmaceutical representative.
*Percentages may not add up to exactly 100% due to rounding.
**Asked on five-point Likert scale (none, little, a little, some, substantial). ‘Yes’ was defined as ‘a little, some, or substantial’. ‘No’ was defined as ‘none, or little.’
doi:10.1371/journal.pone.0012193.t001
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percent reported that their workplaces had rules banning both
meeting with PRs and gifts.
The extent of involvement in promotional activities
Table 2 shows respondents’ involvement in promotional
activities. Most physicians met with PRs, received drug samples
and stationery, and participated in industry-sponsored continuing
medical education (CME) events at and outside the workplace.
Half accepted meals outside the workplace and financial subsidies
to attend CME events. On average, they met with PRs seven times
per month and received gifts or participated in events once to
twice per month. Internists met with PRs most frequently (ten
times per month), followed by general surgeons and orthopedic
surgeons (eight times per month), pediatricians and ophthalmol-
ogists (seven times per month), psychiatrists (six times per month),
and obstetrician-gynecologists (five times per month).
Physician characteristics that predict involvement in
specific types of promotional activities
Multiple logistic regression analyses identified independent
predictors of physician involvement in specific types of promo-
tional activities (Table S1).
Meetings with PRs. Physicians whose workplaces banned
both meeting with PRs and gifts were less likely to meet with PRs
than those whose workplaces without such rules. No other
predictors were identified.
Drug samples. Physicians in practice for 21 years or more
were less likely to receive drug samples than those in practice for
20 years or less. Physicians whose workplaces banned both
meetings with PRs and gifts were less likely to receive drug
samples. Internists, orthopedic surgeons, pediatricians, and
ophthalmologists were more likely than psychiatrists to receive
drug samples.
Stationery such as pens and notepads. Physicians whose
workplace banned both meetings with PRs and gifts were less
likely to receive stationery. No other predictors were identified.
Meals outside the workplace. Female (vs. male) physicians,
physicians in practice 21 years or more (vs. 20 years or less), and
hospital-based (vs. office-based) physicians, and physicians whose
workplaces banned both meetings with PRs and gifts or banned
gifts only were less likely to accept meals outside the workplace.
Orthopedic surgeons were more likely to accept such meals than
obstetrician-gynecologists and ophthalmologists.
Industry-sponsored CME events at the workplace.
Female (vs. male) and hospital-based (vs. office-based) physicians
were more likely to participate in industry-sponsored CME events
at the workplace. Obstetrician-gynecologists were less likely than
internists to participate in such events.
Industry-sponsored CME events outside the workplace.
Physicians whose workplaces banned both meetings with PRs and
gifts were less likely to participate in industry-sponsored CME
events outside the workplace than those whose workplaces had no
such rules. No other predictors were identified.
Financial subsidies to attend CME events. Obstetrician-
gynecologists and ophthalmologists were less likely to receive
financial subsidies to attend CME events than the other specialists.
Physicians whose workplaces banned both meetings with PRs
and gifts or banned gifts only were less likely to receive such
subsidies.
Attitudes toward relationships with PRs
For graphical presentation, answers were aggregated into agree,
neutral, and disagree (Figure 1). Informational Value Scores were
calculated for the 1405 physicians (99.6%) who completed all three
items. Cronbach’s alpha for Informational Value Scores was 0.75.
The mean Informational Value Score was 0.66 (SD, 0.20; range
0–1.0), indicating that physicians were likely to believe that PRs
are a valuable source of information. Their perceptions about PRs’
informational value for new medications were higher than that for
well-established ones (p,.001). Immunity Scores were calculated
for 1405 physicians (99.6%) who completed all three items.
Cronbach’s alpha for Immunity Scores was 0.75. The mean
Immunity Score was 0.69 (SD, 0.20; range 0–1.0), indicating that
they believed that they were immune from having their practice
influenced by discussions with and gifts from PRs. While most
thought that their own and their colleagues’ prescribing behaviors
were not likely to be influenced, they believed that their colleagues
were more likely to be influenced than themselves (p,.001).
Appropriateness Scores were calculated for 1405 physicians
(99.6%) who completed both items. Cronbach’s alpha for
Appropriateness Scores was 0.65. The mean Appropriateness
Score was 0.30 (SD, 0.23; range 0–1.0), indicating that they
thought gifts from PRs were more likely to be inappropriate than
to be appropriate. Physicians thought that gifts of low value were
more appropriate than those of high value. They were divided
about the appropriateness of low-value gifts (28% were in favor vs.
37% opposed).
Table 2. Physician involvement in various types of pharmaceutical promotional activities.
Type of pharmaceutical promotional activities
Number of respondents who meet with
PRs, receive gifts, or participate in events Frequency of involvement per month
Number/Total number (%) Mean (SD)
Meetings with PRs 1383/1407 (98) 7.1 (5.3)
Drug samples 1190/1408 (85) 1.4 (1.5)
Stationery such as pens and notepads 1347/1408 (96) 2.2 (2.2)
Meals outside the workplace 697/1410 (49) 0.6 (0.8)
Industry-sponsored CME events at the workplace 1132/1410 (80) 1.1 (1.0)
Industry-sponsored CME events outside the workplace 1315/1408 (93) 1.2 (0.9)
Financial subsidies to attend CME events 696/1410 (49) 0.6 (0.7)
Abbreviations: PR, pharmaceutical representative; CME, continuing medical education.
doi:10.1371/journal.pone.0012193.t002
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promotional activities and attitudes
There were modest but statistically significant positive correla-
tions between Promotional Activity Index Score and Information-
al Value Score (r=0.161; p,.001) and between Promotional
Activity Index Score and Appropriateness Score (r=0.158;
p,.001). There was no correlation between Promotional Activity
Index Score and Immunity Score (r=0.038; p=.159).
Differences in the extent of involvement in promotional
activities according to self-reported prescribing
behaviors
The extent of involvement in promotional activities was greater
among physicians who prefer to ask PR for information when a
new medication becomes available, physicians who are not
satisfied with the patient encounter ending only with advice, and
physicians who prefer to prescribe brand-name medications when
generic options are available (Table 3). There was no statistically
significant difference in the extent of involvement according to
such self-reported prescribing behaviors as (1) a greater willingness
to prescribe a new medication to a few patients and monitor
outcomes when it becomes available or (2) to agree with patients’
requests to prescribe medications that are not clinically indicated.
Discussion
Most physicians in our survey were involved in promotional
activities. The extent of such involvement varied according to
certain physician characteristics. Many physicians valued PRs as a
source of information and believed they were unlikely to be
influenced by promotional activities. They were divided about the
appropriateness of low-value gifts. The extent of involvement was
positively correlated with the attitudes that PRs are a valuable
source of information and that gifts are appropriate. The extent of
such involvement was higher among physicians who prefer to ask
PRs for information when a new medication becomes available,
physicians who are not satisfied with patient encounters ending
only with advice, and physicians who prefer to prescribe brand-
name medications.
Practicing physicians in Japan met with PRs five to ten times per
month depending on specialty. These findings are similar to those
of a recent national survey in the US, which found that internists
met with PRs ten times per month, pediatricians eight times per
month, and surgeons four times per month [11]. In our survey,
Japanese physicians received various types of gifts or participated
in promotional CME events once to twice per month, which is
likely to be an underestimate because the maximum number that
could be indicated in our survey was six gifts or events. Physicians
might be receiving gifts or participating in events beyond this
number.
Most physicians attended industry-sponsored CME events
outside the workplace. One explanation for this finding may be
that professional medical associations require physicians to earn
CME credits and the pharmaceutical industry sponsors educa-
tional programs offering credits.
In our survey, physician-reported educational experiences in
physician-industry relationships and critical appraisal skills did not
predict the frequency of involvement in promotional activities.
This may be due to inaccurate self-assessment of respondents’
personal levels of educational experiences.
Multivariate logistic regression models identified independent
predictors of physician involvement in types of promotional
activities. Of note, while bans on gifts only lessened the likelihood
of physicians’ accepting meals outside the workplace and financial
subsidies to attend CME events, bans on both meetings with PRs
and gifts lessened the likelihood of their meetings with PRs,
receiving drug samples, receiving stationery, and participating in
industry-sponsored CME events outside the workplace. Effective
rules banning not only gifts from PRs but also meeting with PRs
may be needed to significantly limit the extent of physician
involvement in promotional activities.
Figure 1. Attitudes toward relationships with pharmaceutical representatives. Abbreviations: PR, pharmaceutical representative; CME,
continuing medical education.
doi:10.1371/journal.pone.0012193.g001
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perceived that the informational value of PRs was higher for new
medications than for well-established ones. One explanation of this
finding may be that physicians can obtain information about well-
established medications from various sources, while they can find
much less information about new medications. Another explana-
tion may be that PRs provide more information about new
medications for promotional purposes. As in other studies
[13,14,16,19], physicians believed that their colleagues were more
likely to be influenced by promotional activities than themselves.
These findings are consistent with a line of social science research
which shows that individuals are susceptible to an unconscious and
unintentional ‘‘self-serving bias’’: judgments of fairness are biased
in favor of self-interests [23]. Physicians were divided about the
appropriateness of accepting low-value gifts. This contrasts with
the findings in other surveys that the majority of respondents
considered low-value gifts as appropriate or not ethically
problematic. There were modest but statistically significant
correlations between the extent of involvement in promotional
activities and attitudes about the informational value of PRs and
the appropriateness of gifts. This finding is consistent with a
national survey of medical students in the US [24], although
measurements of promotional activities and attitudes were not
identical in both surveys. The mean Promotional Activity Index
Scores were slightly but statistically significantly higher among
physicians who prefer to ask PRs for information about a new
medication, those who are not satisfied with patient encounters
ending only with advice, and those who prefer to prescribe brand-
name medications. These findings suggest but do not prove that
promotional activities have a modest impact on physicians’
prescribing behaviors. Ideally, intervention studies are needed to
prove whether and to what extent promotional activities affect
physicians’ prescribing behaviors.
Our survey has several limitations. First, the fact that our survey
sample was not selected randomly might have compromised its
representativeness. In order to overcome this limitation, we
devised our sampling method based on national demographic
data of all registered physicians in 2004 [21]. The background
information of our respondent - such as sex, years in practice, and
practice settings - did not significantly differ from national data.
Second, despite the use of the standard techniques for improving
responses to mailed surveys, the overall response rate did not reach
60%, generally considered to be necessary for the validity of a
survey [25]. Third, the respondents might have reported attitudes
and behaviors that are socially desirable, although we attempted to
minimize this bias by ensuring the anonymity of the respondents.
Fourth, the cross-sectional nature of the survey does not allow us
to infer causality of the associations. Fifth, our results may not be
generalizable to physicians in countries other than Japan because
of differences in the context. The Japanese healthcare system has
distinctive characteristics such as coverage of all citizens by
universal health insurance system, a lack of a primary care system,
few certified generalist physicians, and guaranteed access to
specialist physicians without a referral. There is much less public
discussion about physician-industry relationships both in the lay
media and the medical literature as compared with the US or
other relevant countries. There is currently no code of ethics
promulgated by industry, professional societies, or the government
of Japan concretely defining appropriate interactions between
physicians and pharmaceutical industry or prohibiting inappro-
priate interactions. There are few formal curricula regarding
physician-industry relationships in undergraduate, graduate and
continuing medical education in Japan.
Involvement in pharmaceutical promotional activities is wide-
spread among practicing physicians in Japan. The extent of such
involvement varies according to certain physician characteristics.
As a group, they are at risk for influence by pharmaceutical
promotional activities. It may be necessary to completely ban not
only receiving gifts but also meetings with PRs to maximally limit
physician involvement in promotional activities, which may lead to
more skeptical attitudes toward promotional activities and
evidence-based prescribing behaviors.
Table 3. Comparisons of Promotional Activity Index Scores according to prescribing behaviors.
Prescribing behavior
Number (%) of
respondents*
Promotional Activity Index
Score** (range, 0–140)
Mean (SD) p-value
When a new medication becomes available,
what I do most commonly first is:***
Ask PRs for information 578/1387 (42) 15.0 (8.4) .002
Seek published literature for effectiveness
or ask colleagues or specialists
758/1387 (55) 13.6 (8.5)
When faced with a patient who expects a prescription
(which is not clinically indicated) my usual response is to:
Prescribe readily or reluctantly 306/1387 (22) 14.8 (8.7) .139
Not prescribe 1081/1387 (78) 14.0 (8.4)
I feel that a patient consultation that ends with me
giving advice only is
Unsatisfactory or somewhat satisfactory 670/1388 (48) 14.9 (8.8) .003
Satisfactory 718/1388 (52) 13.5 (8.1)
When generic options are available, I think we should
prescribe:
Brand name medications 322/1396 (23) 15.3 (9.5) .005
Neutral or generic medications 1074/1396 (77) 13.8 (8.0)
Abbreviation: PR, pharmaceutical representative.
*Percentages may not add up to exactly 100% due to rounding.
**Promotional Activity Index Score expresses the frequency of meeting with PRs, receiving gifts, and participating in promotional events listed in our survey in a typical
four-week period.
***We also compared promotional activity index scores between those who answered ‘use on a few patients and monitor’ and ‘seek published literature for
effectiveness or ask colleagues or specialists’ and found no difference (13.3 [7.4] vs. 13.6 [8.5]; p=.803).
doi:10.1371/journal.pone.0012193.t003
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